Santiago Alonso Tobar Leitão

Dr. Santiago Alonso Tobar Leitão

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Conservation Physiology
Verified
Journal Article
Open access
PDF file
DGDaphne Wrobel Goldberg
Daphne Wrobel Goldberg
Santiago Alonso Tobar LeitãoSantiago Alonso Tobar Leitão
Santiago Alonso Tobar Leitão
MGMatthew H. Godfrey
Matthew H. Godfrey
GLGustave Gilles Lopez
Gustave Gilles Lopez
ASArmando José Barsante Santos
Armando José Barsante Santos
VBVera Lúcia Freire da Cunha Bastos
Vera Lúcia Freire da Cunha Bastos
Female sea turtles have rarely been observed foraging during the nesting season. This suggests that prior to their migration to nesting beaches the females must store sufficient energy and nutrients at their foraging grounds and must be physiologically capable of undergoing months without feeding. Leptin (an appetite-suppressing protein) and ghrelin (a hunger-stimulating peptide) affect body weight by influencing energy intake in all vertebrates. We investigated the levels of these hormones and other physiological and nutritional parameters in nesting hawksbill sea turtles in Rio Grande do Norte State, Brazil, by collecting consecutive blood samples from 41 turtles during the 2010–2011 and 2011–2012 reproductive seasons. We found that levels of serum leptin decreased over the nesting season, which potentially relaxed suppression of food intake and stimulated females to begin foraging either during or after the post-nesting migration. Concurrently, we recorded an increasing trend in ghrelin, which may have stimulated food intake towards the end of the nesting season. Both findings are consistent with the prediction that post-nesting females will begin to forage, either during or immediately after their post-nesting migration. We observed no seasonal trend for other physiological parameters (values of packed cell volume and serum levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, γ-glutamyl transferase, low-density lipoprotein, and high-density lipoprotein). The observed downward trends in general serum biochemistry levels were probably due to the physiological challenge of vitellogenesis and nesting in addition to limited energy resources and probable fasting.

1 November 2021 in Life Sciences
Verified
Journal Article
Closed access
Santiago Alonso Tobar LeitãoSantiago Alonso Tobar Leitão
Santiago Alonso Tobar Leitão
DSDOUGLAS DOS SANTOS SOARES
DOUGLAS DOS SANTOS SOARES
NJNelson Carvas Junior
Nelson Carvas Junior
RZRafael Zimmer
Rafael Zimmer
NLNataniel Floriano Ludwig
Nataniel Floriano Ludwig
MAMichael Andrades
Michael Andrades

31 August 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
LGLivia Adams Goldraich
Livia Adams Goldraich
Santiago Alonso Tobar LeitãoSantiago Alonso Tobar Leitão
Santiago Alonso Tobar Leitão
FSFernando Luis Scolari
Fernando Luis Scolari
FMFabiana Marcondes-Braga
Fabiana Marcondes-Braga
MBMarcely Gimenes Bonatto
Marcely Gimenes Bonatto
NCNadine Clausell
Nadine Clausell
: Heart transplantation is the standard of therapy for patients with end-stage heart disease. Since the first human-to-human heart transplantation, performed in 1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and surveillance of long-term complications have drastically increased recipient survival. However, there are yet many challenges in the modern era of heart transplantation in which immunosuppression may play a key role in further advances in the field. A fine-tuning of immune modulation to prevent graft rejection while avoiding side effects from over immunosuppression has been the vital goal of basic and clinical research. Individualization of drug choices and strategies, taking into account the recipient's clinical characteristics, underlying heart failure diagnosis, immunologic risk and comorbidities seem to be the ideal approaches to improve post-transplant morbidity and survival while preventing both rejection and complications of immunosuppression. : The aim of the present review is to provide a practical, comprehensive overview of contemporary immunosuppression in heart transplantation. Clinical evidence for immunosuppressive drugs is reviewed and practical approaches are provided. Cardiac allograft rejection classification and up-to-date management are summarized. Expanding therapies, such as photophoresis, are outlined. Drug-to-drug interactions of immunosuppressive agents focused on cardiovascular medications are summarized. Special situations involving heart transplantation such as sarcoidosis, Chagas diseases and pediatric immunosuppression are also reviewed. The evolution of phamacogenomics to individualize immunosuppressive therapy is described. Finally, future perspectives in the field of immunosuppression in heart transplantation are highlighted.

17 February 2007 in Fish Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
CSC. M. C. Salles
C. M. C. Salles
PGP. Gagliano
P. Gagliano
Santiago Alonso Tobar LeitãoSantiago Alonso Tobar Leitão
Santiago Alonso Tobar Leitão
JSJ. B. Salles
J. B. Salles
HGHerbert L. de Matos Guedes
Herbert L. de Matos Guedes
Salvatore Giovanni De-SimoneSalvatore Giovanni De-Simone
Salvatore Giovanni De-Simone

1 May 2014 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
RHRachel Ann Hauser-Davis
Rachel Ann Hauser-Davis
FBFrederico Freire Bastos
Frederico Freire Bastos
RDRafael Ferreira Dantas
Rafael Ferreira Dantas
Santiago Alonso Tobar LeitãoSantiago Alonso Tobar Leitão
Santiago Alonso Tobar Leitão
JNJayme da Cunha Bastos Neto
Jayme da Cunha Bastos Neto
MAMarco Aurélio Zezzi Arruda
Marco Aurélio Zezzi Arruda

1 June 2019 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
DSDOUGLAS DOS SANTOS SOARES
DOUGLAS DOS SANTOS SOARES
GPGraziela Hünning Pinto
Graziela Hünning Pinto
ALAmanda Lopes
Amanda Lopes
DCDaniel Sturza Lucas Caetano
Daniel Sturza Lucas Caetano
TNThaiane Gomes Nascimento
Thaiane Gomes Nascimento
ABAndreia Biolo
Andreia Biolo
Exercise promotes physiological cardiac hypertrophy and activates the renin-angiotensin system (RAS), which plays an important role in cardiac physiology, both through the classical axis [angiotensin II type 1 receptor (AT1R) activated by angiotensin II (ANG II)] and the alternative axis [proto-oncogene Mas receptor (MASR) activated by angiotensin-(1–7)]. However, very intense exercise could have deleterious effects on the cardiovascular system. We aimed to analyze the cardiac hypertrophy phenotype and the classical and alternative RAS axes in the myocardium of mice submitted to swimming exercises of varying volume and intensity for the development of cardiac hypertrophy. Male Balb/c mice were divided into three groups, sedentary, swimming twice a day without overload (T2), and swimming three times a day with a 2% body weight overload (T3), totaling 6 wk of training. Both training groups developed similar cardiac hypertrophy, but only T3 mice improved their oxidative capacity. We observed that T2 had increased levels of MASR, which was followed by the activation of its main downstream protein AKT; meanwhile, AT1R and its main downstream protein ERK remained unchanged. Furthermore, no change was observed regarding the levels of angiotensin peptides, in either group. In addition, we observed no change in the ratio of expression of the myosin heavy chain β-isoform to that of the α-isoform. Fibrosis was not observed in any of the groups. In conclusion, our results suggest that increasing exercise volume and intensity did not induce a pathological hypertrophy phenotype, but instead improved the oxidative capacity, and this process might have the participation of the RAS alternative axis.